Elena Levantini

I am a senior research leader with extensive experience in cancer biology and translational oncology, currently focusing on the molecular mechanisms driving therapy resistance in non-small cell lung cancer (NSCLC). Over the course of my career, I have led interdisciplinary teams, integrating genomics, transcriptomics, epigenomics, metabolomics, and functional genomics to uncover novel therapeutic targets and biomarkers. My research emphasizes a mechanistic understanding of tumor evolution, heterogeneity, and metabolic adaptation, aiming to translate molecular insights into strategies that improve patient outcomes. I have a strong track record of successfully managing complex projects, securing competitive funding, and mentoring emerging scientists, fostering a collaborative and innovative research environment. My leadership style is grounded in scientific rigor, strategic vision, and a commitment to excellence. I am passionate about leveraging cutting-edge technologies and integrative approaches to address critical challenges in cancer biology, while advancing precision medicine and translational research. I am particularly motivated by the opportunity to bridge fundamental discoveries with therapeutic applications, guiding my team to push the boundaries of knowledge and impact the field of oncology at both a scientific and clinical level.